Next generation sustained-release formulations for a variety of peptidesExecutive summary first biocompatible pharmaceutical formulations progress to preclinical modelsnew sustained-release drug delivery platforms for peptides, melanocortinsaim to predict drug release kinetics from new formulationsliquid formulation allows flexible dosing through adjusting injection volumesperseverance during 10 years of in-house research MELBOURNE, Australia, Sept. 28, 2025 (GLOBE NEWSWIRE) -- CLINUVEL today announced that ...